Your browser doesn't support javascript.
loading
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders.
Rossignol, Julien; Ouedrani, Amani; Livideanu, Cristina Bulai; Barete, Stéphane; Terriou, Louis; Launay, David; Lemal, Richard; Greco, Celine; Frenzel, Laurent; Meni, Cecile; Bodemere-Skandalis, Christine; Polivka, Laura; Collange, Anne-Florence; Hachichi, Hassiba; Bouzourine, Sonia; Messaoud, Djazira Nait; Negretto, Mathilde; Vendrame, Laurence; Jambou, Marguerite; Gousseff, Marie; Durupt, Stéphane; Lega, Jean-Christophe; Durand, Jean-Marc; Gaudy, Caroline; Damaj, Gandhi; Gourin, Marie-Pierre; Hamidou, Mohamed; Bouillet, Laurence; Le Mouel, Edwige; Maria, Alexandre; Zunic, Patricia; Cabrera, Quentin; Vincent, Denis; Lavigne, Christian; Riviere, Etienne; Gourguechon, Clement; Courbebaisse, Marie; Lebeaux, David; Parfait, Béatrice; Friedlander, Gérard; Brignier, Anne; Lhermitte, Ludovic; Molina, Thierry Jo; Bruneau, Julie; Agopian, Julie; Dubreuil, Patrice; Ranta, Dana; Mania, Alexandre; Arock, Michel; Staropoli, Isabelle.
Affiliation
  • Rossignol J; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Ouedrani A; Paris University, Necker-Enfants Malades Institute, CNRS UMR 8253 and INSERM UMR1151, Necker-Enfants Malades University Hospital, Paris, France; Laboratory of Immunoregulation and Immunopathology, Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Livideanu CB; French Reference Center for Mastocytosis (CEREMAST), Department of Dermatology, Hôpital Larrey, Toulouse University Hospital, Toulouse, France.
  • Barete S; French Reference Center for Mastocytosis (CEREMAST), Department of Dermatology, Pitié-Salpêtrière University Hospital, APHP, Paris, France.
  • Terriou L; University Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.
  • Launay D; University Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.
  • Lemal R; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France.
  • Greco C; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Frenzel L; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Meni C; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Bodemere-Skandalis C; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Polivka L; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Collange AF; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France.
  • Hachichi H; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Bouzourine S; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Messaoud DN; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Negretto M; French Reference Center for Mastocytosis (CEREMAST), Department of Dermatology, Hôpital Larrey, Toulouse University Hospital, Toulouse, France.
  • Vendrame L; Paris University, Necker-Enfants Malades Institute, CNRS UMR 8253 and INSERM UMR1151, Necker-Enfants Malades University Hospital, Paris, France.
  • Jambou M; Paris University, Necker-Enfants Malades Institute, CNRS UMR 8253 and INSERM UMR1151, Necker-Enfants Malades University Hospital, Paris, France.
  • Gousseff M; Department of Internal Medicine, Bretagne Atlantique Hospital, Vannes, France.
  • Durupt S; Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon, France.
  • Lega JC; Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon, France.
  • Durand JM; Department of Internal Medicine, Aix-Marseille University, Timone University Hospital, Marseille, France.
  • Gaudy C; Department of Internal Medicine, Aix-Marseille University, Timone University Hospital, Marseille, France.
  • Damaj G; Haematology Institute, Normandy University School of Medicine, Caen, France.
  • Gourin MP; Laboratory of Hematology, Dupuytren University Hospital, Limoges, France.
  • Hamidou M; Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France.
  • Bouillet L; Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble, France.
  • Le Mouel E; Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
  • Maria A; Department of Internal Medicine, Montpellier University Hospital, Montpellier, France.
  • Zunic P; Department of Haematology, Sud Réunion University Hospital, Saint Pierre, La Réunion, France.
  • Cabrera Q; Department of Haematology, Sud Réunion University Hospital, Saint Pierre, La Réunion, France.
  • Vincent D; Department of Pneumology and Internal Medicine, Caremeau University Hospital, Nimes, France.
  • Lavigne C; Department of Internal Medicine, Angers University Hospital, Angers, France.
  • Riviere E; Department of Internal Medicine, Bordeaux University Hospital, Haut-Lévêque Hospital, Pessac, France.
  • Gourguechon C; Department of Hematology, Amiens University Hospital, Amiens, France.
  • Courbebaisse M; Paris University, Necker-Enfants Malades Institute, CNRS UMR 8253 and INSERM UMR1151, Necker-Enfants Malades University Hospital, Paris, France; Department of Physiology-Functional Renal Explorations, Hôpital Européen Georges Pompidou University Hospital, Paris, France.
  • Lebeaux D; Service de Microbiologie, Unité Mobile d'Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France; Université de Paris, Paris, France.
  • Parfait B; Centre de Ressources Biologiques, Hôpital Cochin, Paris, France; Paris University, Institut Cochin INSERM UMR1016, Paris, France.
  • Friedlander G; Paris University, Necker-Enfants Malades Institute, CNRS UMR 8253 and INSERM UMR1151, Necker-Enfants Malades University Hospital, Paris, France.
  • Brignier A; Therapeutic Apheresis Unit, Saint-Louis University Hospital, APHP, Paris, France.
  • Lhermitte L; Laboratory of Onco-Hematology, Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Molina TJ; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France; Pathology Department, Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Bruneau J; Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France; Pathology Department, Necker-Enfants Malades University Hospital, APHP, Paris, France.
  • Agopian J; CRCM, [Signaling, Hematopoiesis and Mechanism of Oncogenesis, CEREMAST, AFIRMM], INSERM U1068, Marseille, France; Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Univ, UM105, Marseille, France; CNRS, UMR7258, Marseille, France.
  • Dubreuil P; CRCM, [Signaling, Hematopoiesis and Mechanism of Oncogenesis, CEREMAST, AFIRMM], INSERM U1068, Marseille, France; Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Univ, UM105, Marseille, France; CNRS, UMR7258, Marseille, France.
  • Ranta D; Department of Haematology, Nancy University Hospital, Nancy, France.
  • Mania A; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France.
  • Arock M; Laboratory of Haematology, Pitié-Salpêtrière University Hospital, Paris, France.
  • Staropoli I; Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France.
J Allergy Clin Immunol Pract ; 10(5): 1356-1364.e2, 2022 05.
Article in En | MEDLINE | ID: mdl-35074600
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis / COVID-19 Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis / COVID-19 Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article